Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Dec. 31, 2019	Jun. 30, 2019
Current assets:
Cash	$ 469,164	$ 41,335
Prepaid expenses		8,005
Deposits and other receivables	1,000	1,000
Total current assets	470,164	50,340
Property and equipment, net (Note 3)	1,922	2,616
Total assets	472,086	52,956
Current liabilities:
Accounts payable and accrued expenses	701,299	715,554
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $37,000 and $36,000, respectively (Note 8)	34,400	33,400
Deferred compensation (Note 5)	537,119	874,162
Loan payable and accrued interest (Note 6)	9,444,576	9,303,270
Total current liabilities	10,717,394	10,926,386
Convertible notes payable - affiliates (Note 7)	4,523,210	3,801,168
Total liabilities	15,240,604	14,727,554
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 30,195,005 and 28,068,688 shares issued, respectively; 29,490,696 and 27,364,379 shares outstanding, respectively
Additional paid-in capital	111,239,449	110,126,802
Subscription receivable - affiliates (Note 9)	(504,650)	(504,650)
Accumulated deficit	(125,551,452)	(124,346,158)
Total Bion’s stockholders’ deficit	(14,816,653)	(14,724,006)
Noncontrolling interest	48,135	49,408
Total deficit	(14,768,518)	(14,674,598)
Total liabilities and deficit	472,086	52,956
Series A Preferred Stock [Member]
Deficit:
Preferred stock
Series C Preferred Stock [Member]
Deficit:
Preferred stock